Cargando…
PD-L1 expression indicates favorable prognosis for advanced lung adenocarcinoma patients treated with pemetrexed
Conventional chemotherapy for lung cancer exerts anti-tumor effects through cytotoxicity, and through immunologic regulation by reducing specific T cell subsets and inducing the expression of programmed death ligand 1 (PD-L1) on tumor cells. Even though pemetrexed has shown huge potential in combina...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630412/ https://www.ncbi.nlm.nih.gov/pubmed/29029512 http://dx.doi.org/10.18632/oncotarget.19973 |